| 7700595 |
Cinnoline compounds |
Baihua Hu, Jay E. Wrobel, Rayomand Jal Unwalla |
2010-04-20 |
|
| 7576215 |
Quinolines and pharmaceutical compositions thereof |
Robert R. Singhaus, Jr., Baihua Hu, James Jetter, Robert L. Morris, David Kaufman +8 more |
2009-08-18 |
$124,238,000 |
| 7531564 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Robert E. McDevitt, Iwan Gunawan, Eric Steven Manas, Heather Harris +3 more |
2009-05-12 |
$187,360,000 |
| 7449455 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2008-11-11 |
$133,324,000 |
| 7247624 |
2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2007-07-24 |
$32,547,000 |
| 7148247 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Robert E. McDevitt, Iwan Gunawan, Eric Steven Manas, Heather Harris +3 more |
2006-12-12 |
$89,011,000 |
| 7138392 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller |
2006-11-21 |
|
| 7132417 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2006-11-07 |
$116,278,000 |
| 7129258 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Robert E. McDevitt, Iwan Gunawan, Eric Steven Manas |
2006-10-31 |
$65,193,000 |
| 7041663 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2006-05-09 |
$48,718,000 |
| 7022733 |
Substituted 2-phenyl benzofurans as estrogenic agents |
Christopher Miller, David Kaufman, Robert L. Morris, Robert R. Singhaus, Jr., John W. Ullrich +4 more |
2006-04-04 |
$39,675,000 |
| 6951852 |
2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2005-10-04 |
$107,491,000 |
| 6924281 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2005-08-02 |
$141,868,000 |
| 6884814 |
Phenyl benzisoxazoles as estrogenic agents |
Michael S. Malamas, Tam Dinh, Iwan Gunawan, Heather Harris, James Keith +1 more |
2005-04-26 |
$326,574,000 |
| 6835729 |
2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2004-12-28 |
$136,214,000 |
| 6794403 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Robert E. McDevitt, Iwan Gunawan, Eric Steven Manas |
2004-09-21 |
$90,653,000 |
| 6787538 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2004-09-07 |
$139,929,000 |
| 6774248 |
Substituted 2-phenyl benzofurans as estrogenic agents |
Christopher Miller, David Kaufman, Robert L. Morris, Robert R. Singhaus, Jr., John W. Ullrich +4 more |
2004-08-10 |
$274,916,000 |
| 6589980 |
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents |
Christopher Miller, Heather Harris, James Keith |
2003-07-08 |
$241,163,000 |
| 6559177 |
5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents |
Christopher Miller, Heather Harris, James Keith |
2003-05-06 |
$160,960,000 |
| 6537971 |
Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols |
Chris P. Miller, Bach D. Tran, Anita Wai-Yin Chan, Arkadiy Zinoviy Rubezhov |
2003-03-25 |
$184,511,000 |
| 6380166 |
Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols |
Chris P. Miller, Bach D. Tran, Anita Wai-Yin Chan, Arkadiy Zinoviy Rubezhov |
2002-04-30 |
$119,158,000 |
| 6326367 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2001-12-04 |
$212,300,000 |
| 6291451 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2001-09-18 |
$184,671,000 |
| 6232307 |
Tissue selective compounds in the treatment of ovarian cancer |
Chris P. Miller, Bach D. Tran, Arthur A. Santilli |
2001-05-15 |
$281,573,000 |